PEG Ratio
Updated 104h ago
Sector Performance
39th percentileMET
0.64x
Sector Median
0.94x
Sector Avg
3.01x
Deep Analysis
The PEG ratio divides a stock’s price-to-earnings (P/E) multiple by its earnings growth rate, so a value below 1.0x can indicate the stock is undervalued relative to its growth.
At 0.64x, MET’s ratio is well below the sector median of 0.97x, placing it in the 38th percentile among peers — meaning it is cheaper than most but not the cheapest. The metric shows a year-over-year change that is not available, but quarter-over-quarter it declined by 1.5% from 0.65x to 0.64x. A low PEG that is still edging lower suggests the stock’s valuation relative to growth is contracting, which may point to reduced investor expectations or a slight margin of safety. For risk-opportunity, the combination of an already low level and a small downward trend does not scream an urgent buy nor a warning sign — it simply reflects a modestly priced growth profile. This metric supports the overall NEUTRAL verdict, as it shows neither extreme undervaluation that would demand a bullish stance nor a deterioration that would trigger bearish concerns.
Frequently Asked Questions
What does the PEG Ratio tell investors about MET?
The PEG ratio adjusts P/E for expected growth. A PEG below 1.0 may signal undervaluation; above 2.0 may suggest the growth story is priced in.
How is the PEG Ratio calculated?
PEG Ratio is calculated as: P/E Ratio / EPS Growth Rate.
Who are MET's closest peers by PEG Ratio?
The closest peers by PEG Ratio include: NUE (0.06x), VLO (0.06x), LNC (0.05x), NKE (0.05x), NCLH (0.05x).
The Formula
P/E Ratio / EPS Growth Rate
Why It Matters
The PEG ratio adjusts P/E for expected growth. A PEG below 1.0 may signal undervaluation; above 2.0 may suggest the growth story is priced in.
Master MET's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full MET research report →MET
0.64x
Sector Median
0.94x
Sector Avg
3.01x
How MET's PEG Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.